Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Regulatory press release

CombiGene: BioStock: Bayer acquires gene therapy company AskBio in billion-dollar deal

Read the release

The pace of development in gene therapies has accelerated; new treatments are on the way and the interest from investors and the life science sector has certainly not diminished. The area has now received further attention with Bayer's acquisition of Asklepios BioPharmaceuticals, which was announced on Monday. The purchase price amounted to two billion USD and another two billion when agreed milestones are reached.

Read the full article on the gene therapy deal at biostock.se:

https://www.biostock.se/en/bayer-acquires-gene-therapy-company-askbio-in-billion-dollar-deal/

This is a pressrelease from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.